title: FISH detection of mixed chimerism in 33 patients submitted to bone marrow transplantation.
abstract: Fluorescence in situ hybridization (FISH) and cytogenetic analysis were carried out in 33 transplanted patients suffering from different hematologic disease using probes for X and Y chromosomes and ABL and BCR genes. FISH showed that recipient cells were invariably present during post-transplant follow-up. Stable minimal residual disease was associated with clinical and hematologic remission, while a progressive increase of host cells was strictly related with disease relapse. Cytogenetic investigation on the same samples showed recipient cells only in few cases. It was concluded that FISH analysis is useful for: (1) characterizing cases in which standard cytogenetic analysis has failed; (2) detecting host cells in sex-mismatched transplanted patients; and (3) evaluating Ph-negative CML with the BCR/ABL rearrangement. The possibility of detecting chromosome rearrangements in interphase nuclei using FISH analysis improves diagnosis and prediction of disease evolution and prompts earlier therapeutic approaches.
authors.affiliation: Instituti di Biologia e Genetica, Università di Chieti, Italy.
authors.forename: G
authors.initials: G
authors.lastname: Palka
authors.forename: L
authors.initials: L
authors.lastname: Stuppia
authors.forename: P
authors.initials: P
authors.lastname: Di Bartolomeo
authors.forename: E
authors.initials: E
authors.lastname: Morizio
authors.forename: R
authors.initials: R
authors.lastname: Peila
authors.forename: P G
authors.initials: PG
authors.lastname: Franchi
authors.forename: G
authors.initials: G
authors.lastname: Calabrese
mesh_terms: D000293:Adolescent; D000328:Adult; D000741:Anemia, Aplastic / Q000473:pathology / Q000628:therapy; D014408:Biomarkers, Tumor; D016026:Bone Marrow Transplantation / Q000473:pathology*; D002648:Child; D002675:Child, Preschool; D002678:Chimera; D005199:Fanconi Anemia / Q000473:pathology / Q000628:therapy; D005260:Female; D005500:Follow-Up Studies; D016044:Fusion Proteins, bcr-abl / Q000235:genetics; D016313:Genes, abl; D006085:Graft Survival; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D007399:Interphase; D007938:Leukemia / Q000473:pathology / Q000628:therapy*; D008297:Male; D008677:Metaphase; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis / Q000473:pathology; D018365:Neoplasm, Residual; D009857:Oncogenes; D010677:Philadelphia Chromosome; D012074:Remission Induction; D012730:Sex Chromosomes; D013789:Thalassemia / Q000473:pathology / Q000628:therapy*; D016896:Treatment Outcome
chemical_list: D014408:Biomarkers, Tumor; D016044:Fusion Proteins, bcr-abl